文献速递鼻科

后鼻神经冷冻消融术后鼻漏复发:一项多中心队列研究

Rhinorrhea Recurrence After Posterior Nasal Nerve Cryoablation: A Multicenter Cohort Study.
PubMed 文献 · Laryngoscope · 2025-01-07

这项多中心回顾性队列研究纳入74例慢性鼻炎伴清水样薄鼻漏且对异丙托溴铵鼻喷雾剂难治的患者,接受后鼻神经冷冻消融术。84%患者初期改善,但在平均31.6个月随访中,95%出现不同程度复发,平均复发时间约5个月,近90%复发者希望进一步治疗。

要点

  • 后鼻神经冷冻消融术可使84%的慢性鼻炎患者清水样薄鼻漏初期改善。
  • 在随访充分的患者中,95%出现复发,平均复发时间约5个月。
  • 近90%的复发患者鼻漏困扰足够严重而希望进一步治疗。

核心结论

  • 后鼻神经冷冻消融术使84%的慢性鼻炎患者清水样薄鼻漏改善。
  • 近90%的患者在治疗后约5个月出现困扰性复发性清水样薄鼻漏。

研究设计与样本

  • 多中心回顾性队列研究,纳入74例接受后鼻神经冷冻消融术治疗慢性鼻炎相关清水样薄鼻漏且对异丙托溴铵鼻喷雾剂难治的患者。
  • 冷冻消融应用于中鼻道后外侧壁。
  • 通过门诊访视或电话调查收集人口学和临床数据,随访至少12个月或直至清水样薄鼻漏复发。

主要发现

  • 74例患者平均年龄58岁,53%为女性;慢性鼻炎亚型中74%为非过敏性、22%为混合性、4%为过敏性;78%为异丙托溴铵鼻喷雾剂应答者。
  • 74例中62例(84%)初期改善。
  • 60例随访充分(平均31.6个月)的患者中,57例(95%)在治疗后平均5个月出现不同程度复发。
  • 复发者中37例(65%)完全复发至术前流涕评分,11例(19%)达到20-25%流涕评分降低。
  • 复发清水样薄鼻漏患者中近90%困扰足够严重而希望进一步治疗。

关键数值与推荐

  • 主要结局指标为基于患者报告的流涕评分(Likert量表,0-5分)的清水样薄鼻漏改善和复发时间及程度。

局限性

  • 证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Posterior nasal nerve (PNN) cryoablation improves chronic rhinitis (CR) symptoms in 70-80% of cases, including clear thin rhinorrhea (CTR). This study's purpose was to determine time to and degree of CTR recurrence following cryoablation. METHODS: A multicenter retrospective cohort study was conducted on patients who underwent PNN cryoablation to treat CR-related CTR refractory to ipratropium bromide nasal spray (IBNS). Cryoablation was applied along middle meatal posterolateral walls. Demographic and clinical data were collected at clinic visits or by phone surveys. Patients were followed for either 12 months minimum, or until CTR recurrence. Primary outcome measures were time to and degree of CTR improvement and recurrence based on patient-reported runny nose scores (Likert scale, 0-5). Additionally, patients were asked whether their recurrent CTR was bothersome enough to require treatment, and their preference for subsequent treatments. RESULTS: Of 74 CR patients, mean age was 58 years, and 53% were female. Regarding CR subtypes, 74% were nonallergic, 22% mixed, and 4% allergic. Additionally, 78% were IBNS responders. Overall, 62 of 74 (84%) initially improved. Of 60 patients with adequate follow-up for recurrence (mean 31.6 months), 57 (95%) recurred to some degree at a mean 5 months post-treatment. Of those who recurred, 37 (65%) recurred completely to preoperative RNSs, and 11 (19%) achieved 20-25% RNS reduction. Almost 90% of those with recurrent CTR were bothered enough to desire further treatment. CONCLUSION: PNN cryoablation led to CTR improvement in 84% of CR patients, with nearly 90% of patients developing bothersome recurrent CTR by about 5 months post-treatment. LEVEL OF EVIDENCE: 4 Laryngoscope, 135:1928-1934, 2025.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Craig JR, Mack C, Vidovich A, et al. Rhinorrhea Recurrence After Posterior Nasal Nerve Cryoablation: A Multicenter Cohort Study. Laryngoscope. 2025. PMID: 39764581. doi:10.1002/lary.31998

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。